Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mok

Showing results (21-30 of 387) with videos related to

Pageof 39
Sort By:
Lancet (London, England)|December 30, 2015
Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?Tony S K Mok, Herbert H Loong
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 11, 2014
Comparison is beyond IPASS and OPTIMALK C Lam, Tony S K Mok
Cancer|August 7, 2009
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigmTony S K Mok, Suresh S Ramalingam
Nature Reviews. Clinical Oncology|May 21, 2014
Lung cancer: dropping bars or rising hoops--phase III outcomes of NSCLCHerbert H Loong, Tony S K Mok
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
The diverse diversityTony S K Mok, Kwok Chi Lam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Special Issue on Global Cancer MedicineLawrence N Shulman, Tony S K Mok
The Lancet. Oncology|October 2, 2013
Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC? - authors' replyTony S K Mok, Yi-Long Wu
Respirology (Carlton, Vic.)|December 17, 2019
Twenty-five years of Respirology: Advances in lung cancerMei-Kim Ang, Tony S K Mok
Molecular Cell|January 21, 2017
An Orphan Riboswitch Unveils Guanidine Regulation in BacteriaWendy W K Mok, Mark P Brynildsen
Current Opinion in Otolaryngology & Head and Neck Surgery|April 7, 2007
The management of neck metastases in nasopharyngeal cancerWilliam I Wei, Vivian W K Mok
Pageof 39

Showing results (21-30 of 387) with videos related to

Sort By:
Pageof 39
Lancet (London, England)|December 30, 2015
Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?Tony S K Mok, Herbert H Loong
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 11, 2014
Comparison is beyond IPASS and OPTIMALK C Lam, Tony S K Mok
Cancer|August 7, 2009
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigmTony S K Mok, Suresh S Ramalingam
Nature Reviews. Clinical Oncology|May 21, 2014
Lung cancer: dropping bars or rising hoops--phase III outcomes of NSCLCHerbert H Loong, Tony S K Mok
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
The diverse diversityTony S K Mok, Kwok Chi Lam
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Special Issue on Global Cancer MedicineLawrence N Shulman, Tony S K Mok
The Lancet. Oncology|October 2, 2013
Intercalated chemotherapy and erlotinib: a viable first-line option for patients with advanced NSCLC? - authors' replyTony S K Mok, Yi-Long Wu
Respirology (Carlton, Vic.)|December 17, 2019
Twenty-five years of Respirology: Advances in lung cancerMei-Kim Ang, Tony S K Mok
Molecular Cell|January 21, 2017
An Orphan Riboswitch Unveils Guanidine Regulation in BacteriaWendy W K Mok, Mark P Brynildsen
Current Opinion in Otolaryngology & Head and Neck Surgery|April 7, 2007
The management of neck metastases in nasopharyngeal cancerWilliam I Wei, Vivian W K Mok
Pageof 39